CAR T-Cell Therapy Research:CAGR of 22.2% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "CAR T-Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.



Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.



【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

https://www.qyresearch.com/reports/2325980/car-t-cell-therapy





CAR T-Cell Therapy Market Summary



According to the new market research report "Global CAR T-Cell Therapy Market Report 2024-2030", published by QYResearch, the global CAR T-Cell Therapy market size is projected to reach USD 19.41 billion by 2030, at a CAGR of 22.2% during the forecast period.

Global CAR T-Cell Therapy MarketSize(US$ Million), 2019-2030
240718-162927.webp (26 KB)

Above data is based on report from QYResearch: Global CAR T-Cell Therapy Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.



Global CAR T-Cell Therapy Top3Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
240718-163014.webp (16 KB)

Above data is based on report from QYResearch: Global CAR T-Cell Therapy Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of CAR T-Cell Therapy include Gilead Sciences, Novartis, etc. In 2023, the global top three players had a share approximately 72.0% in terms of revenue.

The CAR T-cell therapy market is driven by its groundbreaking potential in treating certain types of cancers, particularly hematologic malignancies like leukemia and lymphoma. This therapy involves modifying a patient's T-cells to better recognize and attack cancer cells, offering a promising option for patients who have not responded to traditional treatments. The increasing incidence of cancer, coupled with significant investments in biotechnology and ongoing clinical trials, supports market growth. Advances in genetic engineering and personalized medicine further bolster the development and adoption of CAR T-cell therapies.



However, the market faces challenges, including the high cost of therapy, which can exceed hundreds of thousands of dollars per patient, limiting accessibility and affordability. Additionally, CAR T-cell therapy can cause severe side effects, such as cytokine release syndrome and neurotoxicity, requiring careful patient monitoring and management. Regulatory hurdles and the complexity of manufacturing personalized therapies also pose significant barriers, necessitating advancements in production processes and regulatory frameworks to ensure broader access and safety.





The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.



The CAR T-Cell Therapy market is segmented as below:

By Company

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)



Segment by Type

CD19 - Targeted
BCMA - Targeted



Segment by Application

Lymphoma
Multiple Myeloma



Each chapter of the report provides detailed information for readers to further understand the CAR T-Cell Therapy market:

Chapter 1: Introduces the report scope of the CAR T-Cell Therapy report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2019-2030)

Chapter 2: Detailed analysis of CAR T-Cell Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2019-2024)

Chapter 3: Provides the analysis of various CAR T-Cell Therapy market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2019-2030)

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2019-2030)

Chapter 5: Sales, revenue of CAR T-Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2019-2030)

Chapter 6: Sales, revenue of CAR T-Cell Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.(2019-2030)

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2019-2024)

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.



Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth CAR T-Cell Therapy competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides CAR T-Cell Therapy comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides CAR T-Cell Therapy market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.



Other relevant reports of QYResearch:

Global CAR T-Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global CAR T-Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global CAR-T Cell Therapy Market Insights, Forecast to 2030
Global CAR T-Cell Therapy Market Insights, Forecast to 2030
Global CAR-T Cell Therapy Market Research Report 2024
CAR-T Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global CAR T-Cell Therapy Market Research Report 2024
Global CAR T-cell Therapy Drug Market Insights, Forecast to 2030
Global CAR T-cell Therapy Drug Market Research Report 2024
Global CAR T-Cell Therapy Agents Market Insights, Forecast to 2030
Global CAR T-Cell Therapy Agents Market Research Report 2024
Global CAR-T Cell Therapy Solution Market Insights, Forecast to 2030
CAR-T Cell Therapy Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global CAR-T Cell Therapy Solution Market Research Report 2024
Universal CAR-T Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Universal CAR-T Cell Therapy Market Research Report 2024
Global and India Universal CAR-T Cell Therapy Market Report & Forecast 2024-2030
Global CAR T-Cell Therapy for Multiple Myeloma Market Insights, Forecast to 2030
Global CAR T-Cell Therapy for Multiple Myeloma Market Research Report 2024
Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Insights, Forecast to 2030

About Us：

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 17 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.